Bayforest Capital Ltd Sells 4,170 Shares of Humana Inc. $HUM

Bayforest Capital Ltd cut its holdings in Humana Inc. (NYSE:HUM) by 95.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 201 shares of the insurance provider’s stock after selling 4,170 shares during the period. Bayforest Capital Ltd’s holdings in Humana were worth $51,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in HUM. Revolve Wealth Partners LLC bought a new stake in Humana in the fourth quarter worth $202,000. Woodline Partners LP lifted its position in Humana by 460.0% in the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after buying an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC lifted its position in Humana by 53.7% in the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after buying an additional 452 shares during the last quarter. Cresset Asset Management LLC lifted its position in Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after buying an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd lifted its position in Humana by 58.5% in the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after buying an additional 879 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on HUM shares. Jefferies Financial Group lowered their price target on Humana from $310.00 to $235.00 and set a “buy” rating for the company in a research report on Thursday, February 12th. Sanford C. Bernstein reiterated an “outperform” rating and set a $344.00 target price on shares of Humana in a research report on Tuesday, January 6th. Guggenheim lowered their target price on shares of Humana from $312.00 to $252.00 and set a “buy” rating for the company in a research note on Thursday, February 12th. Wolfe Research cut their price target on shares of Humana from $325.00 to $250.00 and set an “outperform” rating on the stock in a report on Monday, April 6th. Finally, Royal Bank Of Canada cut shares of Humana from an “outperform” rating to a “sector perform” rating and cut their price target for the stock from $322.00 to $189.00 in a report on Thursday, February 12th. Seven research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average target price of $222.09.

Humana Stock Down 1.2%

Shares of NYSE:HUM opened at $214.85 on Friday. The business’s 50 day moving average is $184.01 and its 200 day moving average is $229.67. The stock has a market cap of $25.79 billion, a P/E ratio of 21.88, a price-to-earnings-growth ratio of 2.33 and a beta of 0.44. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $315.35. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, topping the consensus estimate of ($4.01) by $0.05. The company had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.Humana’s quarterly revenue was up 11.3% on a year-over-year basis. During the same period last year, the business posted ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Sell-side analysts predict that Humana Inc. will post 9.05 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.6%. Humana’s dividend payout ratio (DPR) is currently 36.05%.

Insider Activity at Humana

In other news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction dated Monday, February 23rd. The shares were purchased at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the purchase, the insider owned 11,657 shares in the company, valued at approximately $2,158,992.97. This represents a 7.47% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.20% of the company’s stock.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.